- About Us
- What We Do
- How We Heal
- Products
- Cartilage Repair Device
- Medeor® Matrix for Soft Tissue Repair
- Meso BioMatrix® Scaffold for Soft Tissue Repair
- Epi-Guide® Bioresorbable Barrier Matrix
- OsseoFit™ Porous Tissue Matrix™
- Vitoss® Scaffold Foam™ Products
- Angio-Seal™ Vascular Closure Device
- QuickCat™ Extraction Catheter
- ThromCat® Thrombectomy System
- Technology Platforms
- How We Partner
- Investor Relations
Cartilage Repair Device
United States
Cartilage Repair Device Technology
Today's techniques for treating chondral or osteochondral defects commonly include microfracture and transplantation procedures. These techniques typically provide temporary relief, however, concerns remain about limited graft availability, morbidity at the autograft donor site, graft hypertrophy, the need for multiple surgical interventions, and excessive cost. These current techniques, though beneficial in temporarily reducing pain, cannot be considered long-term solutions.
Paving the Way
Kensey Nash Corporation is developing technologies to address these deficiencies. Significant preclinical research and development using our proprietary biomaterial technologies has yielded promising designs. Preclinical studies have been conducted with some of the premier academic institutes in the US. The success of these studies has prompted Kensey Nash to seek IDE approval with the United States Food and Drug Administration to begin a human clinical investigation.
CAUTION - INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL LAW TO INVESTIGATIONAL USE.
European Union
Cartilage Repair Device Technology
Today's techniques for treating chondral or osteochondral defects commonly include microfracture and transplantation procedures. These techniques typically provide temporary relief, however, concerns remain about limited graft availability, morbidity at the autograft donor site, graft hypertrophy, the need for multiple surgical interventions, and excessive cost. These current techniques, though beneficial in temporarily reducing pain, cannot be considered long-term solutions.
Biphasic Design
Kensey Nash has developed technologies to address these deficiencies. The Cartilage Repair Device (CRD) is a unique synthetic bioresorbable implant designed to address chondral and osteochondral defects. CRD technology utilizes a biphasic design containing two discrete layers, each specifically engineered to favor the growth of the histologically distinct tissues of articular cartilage and subchondral bone.
The chondral phase consists of a unique Type I collagen matrix that provides a malleable, flexible substratum that allows cell infiltration and de novo formation of hyaline tissue. The subchondral phase consists of β -TCP (tricalcium phosphate) mineral suspended within a porous bioresorbable synthetic polymer scaffold. This matrix provides an appropriate mechanical and chemical environment to facilitate the influx of cells and remodeling into normal bony architecture, an important component in a successful cartilage regeneration effort.
